Standout Papers
- MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma (2005)
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 (2012)
- Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology (2009)
- Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) (2016)
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020)
Immediate Impact
7 by Nobel laureates 17 from Science/Nature 153 standout
Citing Papers
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
2024 Standout
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
Works of Johan M. Kros being referenced
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
2012 Standout
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Johan M. Kros | 11396 | 6786 | 4571 | 4614 | 270 | 18.8k | |
| Daniel J. Brat | 10901 | 7590 | 3412 | 4734 | 306 | 22.3k | |
| Khê Hoang‐Xuan | 10927 | 4449 | 3893 | 3174 | 325 | 16.9k | |
| Torsten Pietsch | 9745 | 9597 | 3193 | 3323 | 396 | 19.0k | |
| Tom Mikkelsen | 9779 | 6296 | 4251 | 4106 | 255 | 18.5k | |
| Marc Sanson | 8462 | 5072 | 3012 | 3689 | 316 | 13.7k | |
| Martin Taphoorn | 14784 | 6387 | 5703 | 4520 | 152 | 21.8k | |
| Stefan M. Pfister | 13955 | 12069 | 3440 | 5417 | 364 | 24.3k | |
| Dominique Figarella‐Branger | 9611 | 5849 | 3226 | 2806 | 417 | 18.3k | |
| Manfred Westphal | 7790 | 5825 | 2740 | 3560 | 427 | 18.1k | |
| Howard A. Fine | 9264 | 8844 | 3714 | 4751 | 231 | 20.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...